↑: Increased with regard to normal levels; ↓: Decreased with regard to normal levels; CTL: Cytotoxic T lymphocyte; MDS: Myelodysplastic syndrome.

This year’s most-viewed articles and videos on myelodysplastic syndromes (MDS) explored patient quality of life, risk factors ...

↑: Increased with regard to normal levels; ↓: Decreased with regard to normal levels; CTL: Cytotoxic T lymphocyte; MDS: Myelodysplastic syndrome.

NEXI-001 is under clinical development by NexImmune and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase II drugs for Myelodysplastic Syndrome have a 30% phase ...

Emavusertib hydrochloride is under clinical development by Curis and currently in Phase II for Myelodysplastic Syndrome.

We recently compiled a list of the 10 Best Penny Stocks to Buy for 2025. In this article, we are going to take a look at ...

Anthony Olson was diagnosed with Myelodysplastic syndromes (MDS) and went on to receive chemo for almost a decade to treat ...

He attended community college and later moved from his parents' house in Helena to study accounting at Montana Tech in Butte.

myelodyplastic syndromes (MDS), having met primary and key secondary endpoints. The COMMANDS study (NCT03682536) - a phase 3 open-label, randomised trial to evaluate the efficacy and safety of ...

Ten companies bucked an overall bearish market sentiment, booking significant gains during the last trading day of the week.

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) saw a significant increase in short interest in December. As of December 15th, there was short interest totalling 13,700 shares, an increase of 23.4% ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...